Abstract
The skin remains an attractive area for drug delivery. The skin, however, often limits the ingress of drugs, because of its very low permeability. Much research, focusing on employing a variety of physical and chemical methods, aimed at reversibly altering skin permeability in favour of compounds, has been reported. Of the many chemical approaches that exist, one comprises the use of vesicular carriers for delivering drugs into and possibly through the skin. This review offers an overview of various vesicles that have been investigated during dermal and transdermal drug delivery research in recent years, with special emphasis on a relatively new carrier, namely the Pheroid™. The progress made to date by our research group with regards to the use of the Pheroid™ as transdermal delivery vector, is also discussed in detail.
Keywords: Elasticity, permeability, pheroid™, skin, mechanism of action, transdermal, vesicular carriers.
Current Pharmaceutical Design
Title:Vesicular Carriers for Skin Drug Delivery: The Pheroid™ Technology
Volume: 21 Issue: 20
Author(s): Dewald Kilian, Yasser Shahzad, Lizelle Fox, Minja Gerber and Jeanetta Du Plessis
Affiliation:
Keywords: Elasticity, permeability, pheroid™, skin, mechanism of action, transdermal, vesicular carriers.
Abstract: The skin remains an attractive area for drug delivery. The skin, however, often limits the ingress of drugs, because of its very low permeability. Much research, focusing on employing a variety of physical and chemical methods, aimed at reversibly altering skin permeability in favour of compounds, has been reported. Of the many chemical approaches that exist, one comprises the use of vesicular carriers for delivering drugs into and possibly through the skin. This review offers an overview of various vesicles that have been investigated during dermal and transdermal drug delivery research in recent years, with special emphasis on a relatively new carrier, namely the Pheroid™. The progress made to date by our research group with regards to the use of the Pheroid™ as transdermal delivery vector, is also discussed in detail.
Export Options
About this article
Cite this article as:
Kilian Dewald, Shahzad Yasser, Fox Lizelle, Gerber Minja and Plessis Du Jeanetta, Vesicular Carriers for Skin Drug Delivery: The Pheroid™ Technology, Current Pharmaceutical Design 2015; 21 (20) . https://dx.doi.org/10.2174/1381612821666150428125812
DOI https://dx.doi.org/10.2174/1381612821666150428125812 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial from Editor-in-Chief (N-Acetylcysteine: More than COPD and IPF in Pulmonary Medicine)
Current Respiratory Medicine Reviews Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses
Current Cancer Drug Targets DC-SIGN Antagonists, a Potential New Class of Anti-Infectives
Current Medicinal Chemistry Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson’s Disease
Current Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery The Surgical Treatment of Diabetic Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Nanotechnology Based Diagnostic and Therapeutic Strategies for Neuroscience with Special Emphasis on Ischemic Stroke
Current Medicinal Chemistry Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte
Current Drug Targets The Neonatal Kidney: Implications for Drug Metabolism and Elimination
Current Drug Metabolism The Use of Immunotherapy to Treat Metastatic Breast Cancer
Current Medicinal Chemistry Charcot Neuroarthropathy: From the Laboratory to the Bedside
Current Diabetes Reviews Vascular Remodelling and Angiogenesis in Asthma: Morphological Aspects and Pharmacological Modulation
Inflammation & Allergy - Drug Targets (Discontinued) α(N)-Heterocyclic Thiosemicarbazones: Iron Chelators that are Promising for Revival of Gallium in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Using Pharmacogenomic Tumor Profiling to Identify Biomarkers of 5-fluorouracil Response in Colorectal Cancer
Current Pharmacogenomics Advances in Stem Cell Therapy for Leukemia
Current Stem Cell Research & Therapy Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
Current Cancer Drug Targets Optimization of Stability Indicating LC Method for the Sensitive In vitro Determination from Solid Lipid Nanoparticles and Ex vivo Analysis from Rat Skin of Etofenamate
Current Pharmaceutical Analysis Identification of Leads from Marine Seaweeds against Human β-tubulin
Letters in Drug Design & Discovery Radiolabeled Organism-Specific Antibodies for Diagnosis and Therapy of Infections
Current Medical Imaging Anti-Infective and Anti-Tumor Agents Based on the Depletion of Immune Suppressive Effects
Current Medicinal Chemistry